Denali Therapeutics Inc
Closed
SectorHealthcare
22.51 -1.79
Overview
Share price change
24h
Min
21.92
Max
23.03
Income | 102K -128M |
|---|---|
EPS | -0.69 |
Employees | 507 |
EBITDA | -937K -126M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +48.57% upside |
Next Earnings | 7 Aug 2026 |
|---|
Market Cap | 1.2B 4.2B |
|---|---|
Previous open | 24.3 |
Previous close | 22.51 |
News Sentiment
By Acuity
50%
50%
153 / 342 Healthcare
Denali Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Denali Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 34.2 USD 48.57%
High 42 USD
Low 25 USD
Based on 12 Wall Street analysts offering 12 month price targets forDenali Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$